25 results
8-K
EX-10.1
ATRX
Adhera Therapeutics, Inc.
29 Jun 23
Entry into a Material Definitive Agreement
4:54pm
, unfair or deceptive trade practices, taxes, environmental protection, occupational health and safety, COVID-19, product quality and safety
8-K
EX-10.1
ATRX
Adhera Therapeutics, Inc.
5 May 23
Entry into a Material Definitive Agreement
4:02pm
, unfair or deceptive trade practices, taxes, environmental protection, occupational health and safety, COVID-19, product quality and safety
8-K
EX-10.1
ATRX
Adhera Therapeutics, Inc.
4 May 23
Entry into a Material Definitive Agreement
4:05pm
, unfair or deceptive trade practices, taxes, environmental protection, occupational health and safety, COVID-19, product quality and safety
8-K
EX-10.1
ddmn2
11 Feb 20
Entry into a Material Definitive Agreement
4:30pm
8-K
EX-10.1
t4xk8zu ffpqk2m
24 Nov 17
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
3en8koict0m8y 9j9
7 Jun 17
Marina Biotech Acquires Prestalia®, a U.S. FDA Approved Drug for Patients Whose Blood Pressure Is Not Adequately Controlled by Monotherapy
12:00am
8-K
EX-10.1
ryfdjj9u0zfxjzyzfo7
20 Mar 12
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
gu77jx vxd
17 Oct 11
Marina Biotech, Inc. Announces a $15 Million Purchase Agreement with Lincoln Park Capital Fund, LLC
12:00am
8-K
EX-10.1
7jh9v5
14 Jan 10
MDRNA, Inc. Raises $5.5 Million in Registered Direct Offering
12:00am
8-K
EX-10.1
wtn3rpzl7p2q
11 Jun 09
Entry into a Material Definitive Agreement
12:00am
8-K/A
EX-10.1
pwbifcb9o83o2
26 Jul 06
Financial Statements and Exhibits
12:00am
8-K
EX-10.1
u0fguu9r7
8 Jun 06
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
cjira
7 Mar 06
Entry into a Material Definitive Agreement
12:00am
8-K
EX-1.1
2j9h6z7z 07fsrwp8le
30 Aug 05
Entry into a Material Definitive Agreement
12:00am